Literature DB >> 17290045

Disparate innate immune responses to persistent and acute Chlamydia pneumoniae infection in chronic obstructive pulmonary disease.

Daniel Droemann1, Jan Rupp, Torsten Goldmann, Ulrike Uhlig, Detlev Branscheid, Ekkehard Vollmer, Peter Kujath, Peter Zabel, Klaus Dalhoff.   

Abstract

RATIONALE: Chlamydia pneumoniae (Cpn) infection may play a role in the pathogenesis of chronic obstructive pulmonary disease (COPD). Few data are available comparing persistent and acute infection of this pathogen in the human respiratory tract.
OBJECTIVES: To study Cpn-induced innate immune responses in lung tissue from patients with COPD and control subjects ex vivo and in vitro.
METHODS: Cpn detection was done by nested polymerase chain reaction, in situ hybridization, and immunohistochemistry ex vivo in unstimulated tissue and in vitro using an acute Cpn infection model. As main endpoints for the assessment of early cellular responses, nuclear factor (NF)-kappaB activation and CXC chemokine ligand (CXCL)-8 expression were evaluated. The role of Toll-like receptors (TLRs) as recognition molecules in Cpn-induced innate responses was tested by blocking experiments.
MEASUREMENTS AND MAIN RESULTS: Fifteen percent of patients with COPD were chronically infected with Cpn in contrast to 0% of control subjects (p < 0.05). There were no differences in CXCL-8 and NF-kappaB expression between infected and noninfected COPD tissue ex vivo. In contrast, acute in vitro infection induced an intense innate immune response including up-regulation of TLR2. Blocking experiments demonstrated the predominant role of TLR2 in induction of the early immune response, whereas no influence on chlamydial infection rates was observed.
CONCLUSIONS: Acute in vitro infection of human lung tissue with Cpn elicited a marked innate response via TLR2, whereas chronic chlamydial infection in patients with COPD was not associated with enhanced cellular activation. These findings suggest different roles of Cpn during acute and chronic stages of pulmonary infection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17290045     DOI: 10.1164/rccm.200607-926OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  13 in total

1.  CXCR7 transcription in human non-small cell lung cancer and tumor-free lung tissues; possible regulation upon chemotherapy.

Authors:  Torsten Goldmann; Daniel Drömann; Janine Radtke; Sebastian Marwitz; Dagmar S Lang; Holger Schultz; Ekkehard Vollmer
Journal:  Virchows Arch       Date:  2008-03       Impact factor: 4.064

Review 2.  Chlamydial zoonoses.

Authors:  Gernot Rohde; Eberhard Straube; Andreas Essig; Petra Reinhold; Konrad Sachse
Journal:  Dtsch Arztebl Int       Date:  2010-03-12       Impact factor: 5.594

3.  Preclinical investigations reveal the broad-spectrum neutralizing activity of peptide Pep19-2.5 on bacterial pathogenicity factors.

Authors:  Lena Heinbockel; Susana Sánchez-Gómez; Guillermo Martinez de Tejada; Sabine Dömming; Julius Brandenburg; Yani Kaconis; Mathias Hornef; Aline Dupont; Sebastian Marwitz; Torsten Goldmann; Martin Ernst; Thomas Gutsmann; Tobias Schürholz; Klaus Brandenburg
Journal:  Antimicrob Agents Chemother       Date:  2013-01-14       Impact factor: 5.191

Review 4.  Chlamydia-induced ReA: immune imbalances and persistent pathogens.

Authors:  Eric Gracey; Robert D Inman
Journal:  Nat Rev Rheumatol       Date:  2011-11-22       Impact factor: 20.543

5.  The TGF-beta-pseudoreceptor BAMBI is strongly expressed in COPD lungs and regulated by nontypeable Haemophilus influenzae.

Authors:  Daniel Drömann; Jan Rupp; Kristina Rohmann; Sinia Osbahr; Artur J Ulmer; Sebastian Marwitz; Kristina Röschmann; Mahdi Abdullah; Holger Schultz; Ekkehard Vollmer; Peter Zabel; Klaus Dalhoff; Torsten Goldmann
Journal:  Respir Res       Date:  2010-05-31

6.  Persistent Chlamydia Pneumoniae serology is related to decline in lung function in women but not in men. Effect of persistent Chlamydia pneumoniae infection on lung function.

Authors:  Thorarinn Gislason; Vilmundur Guðdnason; Bryndis Benediktsdottir; Isleifur Olafsson; Thor Aspelund; Bjarni Thjodleifsson; Christer Janson
Journal:  BMC Pulm Med       Date:  2010-08-25       Impact factor: 3.317

7.  Differences in innate immune responses correlate with differences in murine susceptibility to Chlamydia muridarum pulmonary infection.

Authors:  Xiaozhou Jiang; Caixia Shen; Hong Yu; Karuna P Karunakaran; Robert C Brunham
Journal:  Immunology       Date:  2009-09-11       Impact factor: 7.397

8.  Pulmonary haptoglobin (pHp) is part of the surfactant system in the human lung.

Authors:  Mahdi Abdullah; Torsten Goldmann
Journal:  Diagn Pathol       Date:  2012-11-20       Impact factor: 2.644

Review 9.  Mesenchymal stem cells in acute lung injury: are they ready for translational medicine?

Authors:  Feng Xu; Yue Hu; Jiebai Zhou; Xiangdong Wang
Journal:  J Cell Mol Med       Date:  2013-07-03       Impact factor: 5.310

10.  A novel human ex vivo model for the analysis of molecular events during lung cancer chemotherapy.

Authors:  Dagmar S Lang; Daniel Droemann; Holger Schultz; Detlev Branscheid; Christian Martin; Anne R Ressmeyer; Peter Zabel; Ekkehard Vollmer; Torsten Goldmann
Journal:  Respir Res       Date:  2007-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.